Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve Audited Standalone Financial Results of the Company alongwith the Auditor Report as on March 31, 2026 & to transact other businesses with the permission of Chair.